Carboplatin News and Research

RSS
Carboplatin is a chemotherapy drug used against some forms of cancer (mainly ovarian carcinoma, lung, head and neck cancers).
Neoadjuvant chemoimmunotherapy highly effective in patients with resectable stage IIIA NSCLC

Neoadjuvant chemoimmunotherapy highly effective in patients with resectable stage IIIA NSCLC

Clinical trial examining the combination of atezolizumab and chemoradiation for patients with limited-stage SCLC reaches accrual

Clinical trial examining the combination of atezolizumab and chemoradiation for patients with limited-stage SCLC reaches accrual

Insight into the Breast Cancer Landscape with Breast Cancer Now

Insight into the Breast Cancer Landscape with Breast Cancer Now

Adding immunotherapy to chemotherapy before surgery improves outcomes for NSCLC patients

Adding immunotherapy to chemotherapy before surgery improves outcomes for NSCLC patients

How malaria drugs could play a part in treating chemotherapy-resistant head and neck cancers

How malaria drugs could play a part in treating chemotherapy-resistant head and neck cancers

30-year-old cancer drug could get another shot, study says

30-year-old cancer drug could get another shot, study says

Trastuzumab combined with trimodality treatment for HER2-overexpressing esophageal cancer found to be ineffective

Trastuzumab combined with trimodality treatment for HER2-overexpressing esophageal cancer found to be ineffective

A class of FDA-approved drugs can effectively stop aggressive uterine cancer

A class of FDA-approved drugs can effectively stop aggressive uterine cancer

Study points to a new, effective treatment option for patients with mesothelioma

Study points to a new, effective treatment option for patients with mesothelioma

Combination of chemotherapy and immune checkpoint inhibitors shows promise in NSCLC patients with untreated brain metastases

Combination of chemotherapy and immune checkpoint inhibitors shows promise in NSCLC patients with untreated brain metastases

Combination of metformin and chemoradiation does not add survival benefit in patients with LA-NSCLC

Combination of metformin and chemoradiation does not add survival benefit in patients with LA-NSCLC

Drug sensitivity of hepatocellular cancer cells may provide new insights on tumor biology

Drug sensitivity of hepatocellular cancer cells may provide new insights on tumor biology

Targeting mTOR pathway can improve the effectiveness of chemotherapies for pediatric brain cancer

Targeting mTOR pathway can improve the effectiveness of chemotherapies for pediatric brain cancer

Drug synthesized from Kentucky-grown plant shows promise in treating ovarian cancer

Drug synthesized from Kentucky-grown plant shows promise in treating ovarian cancer

Phase 3 DREAM3R trial opens for malignant pleural mesothelioma

Phase 3 DREAM3R trial opens for malignant pleural mesothelioma

Nivolumab monotherapy is effective treatment option for relapsed malignant mesothelioma

Nivolumab monotherapy is effective treatment option for relapsed malignant mesothelioma

First-ever phase 3 advanced anal cancer trial opens for patient enrollment

First-ever phase 3 advanced anal cancer trial opens for patient enrollment

New model can predict the risk of adverse side effects of cancer treatment

New model can predict the risk of adverse side effects of cancer treatment

Combination therapy improves survival rates for women with aggressive endometrial cancer

Combination therapy improves survival rates for women with aggressive endometrial cancer

International trial shows better option for treating people with inoperable anal cancer

International trial shows better option for treating people with inoperable anal cancer